Echo Therapeutics (ECTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2002 | 09-2002 | 06-2002 | 03-2002 | 12-2001 | |
| Operating Expenses | 1,420 | 1,084 | 1,048 | 640 | 718 |
| Operating Income | -1,420 | -1,084 | -1,048 | -640 | -3,441 |
| Other Income | 11 | 20 | 2 | 1 | 472 |
| Pre-tax Income | -1,408 | -1,064 | -1,046 | -638 | -2,969 |
| Net Income Continuous | -1,408 | -1,064 | -1,046 | -638 | -2,977 |
| Net Income | $-1,408 | $-1,064 | $-1,046 | $-638 | $-2,977 |
| EPS Basic Total Ops | -4.00 | -11.00 | -27.00 | -28.00 | -181.90 |
| EPS Basic Continuous Ops | -5.57 | -11.48 | -25.96 | -24.43 | -136.32 |
| EPS Diluted Total Ops | -4.00 | -11.00 | -27.00 | -28.00 | -181.90 |
| EPS Diluted Continuous Ops | -5.57 | -11.48 | -25.96 | -24.43 | -136.32 |
| EBITDA(a) | $-1,376 | $-1,047 | $-1,014 | $-605 | $-681 |